首站-论文投稿智能助手
典型文献
Stress reduction via neuro-emotional technique to achieve the simultaneous resolution of chronic low back pain with multiple inflammatory and biobehavioural indicators:A randomized,double-blinded,placebo-controlled trial
文献摘要:
Background:Beginning with the concepts of stress developed by Selye,an approach to stress and pain management,known as neuro-emotional technique(NET),has been developed.It is a treatment approach based on the principle that the stressor effects of dormant and/or current unresolved issues or trauma are what determine one's bodily responses.These responses are relatively personalized to the conditioned,experiential and emotional reality of the individual.Objective:To determine the effect of NET on patients with chronic low back pain(CLBP)over time.Design,setting,participants,and interventions:In a randomized,double-blinded,placebo-controlled study conducted in a single clinic,NET or control treatments were given twice weekly for 4 weeks in a popu-lation of 112 patients.Main outcome measures:Outcome measures,including Oswestry Disability Index,Quadruple Visual Analogue Scale,the psychoneuroimmunology markers of blood serum levels of C-reactive protein,tumour necrosis factor-α,interleukin-1(IL-1),IL-6,and IL-10,and 10 dimensions of the Short Form Health Survey scale,were assessed at baseline and at 1,3 and 6 months following the intervention period.Results:Compared to placebo,NET produced clinical and statistical significance(P<0.001)via declines of virtually all physiological,pain and disability markers,accompanied by gains in quality-of-life indicators at 0(baseline),1,3 and 6 months.Reductions of the percentages of patients whose 5 biomarkers lay out-side the normative range were achieved at 1,3 and 6 months by NET but not control interventions.Conclusion:A randomized,controlled trial of CLBP patients indicated that 8 NET interventions,compared to placebo,produced clinically and statistically significant reductions in pain,disability and inflammatory biomarkers,and improvements in quality-of-life measures.Trial registration:The trial was registered with the Australian and New Zealand Clinical Trials Registry(No.ACTRN12608000002381).
文献关键词:
作者姓名:
Peter Bablis;Henry Pollard;Anthony L.Rosner
作者机构:
Universal Health,New South Wales 2028,Australia;School of Medical and Applied Sciences,University of Central Queensland,Brisbane,New South Wales 4000,Australia;Medical Information Services,MA 02479-4149,United States
引用格式:
[1]Peter Bablis;Henry Pollard;Anthony L.Rosner-.Stress reduction via neuro-emotional technique to achieve the simultaneous resolution of chronic low back pain with multiple inflammatory and biobehavioural indicators:A randomized,double-blinded,placebo-controlled trial)[J].结合医学学报(英文版),2022(02):135-144
A类:
biobehavioural,psychoneuroimmunology,Reductions,ACTRN12608000002381
B类:
Stress,via,emotional,technique,simultaneous,resolution,chronic,back,pain,multiple,inflammatory,indicators,randomized,double,blinded,placebo,controlled,trial,Background,Beginning,concepts,developed,by,Selye,approach,management,known,NET,has,been,It,principle,that,stressor,effects,dormant,current,unresolved,issues,trauma,what,determine,bodily,responses,These,relatively,personalized,conditioned,experiential,reality,individual,Objective,To,patients,CLBP,over,Design,setting,participants,interventions,study,conducted,single,treatments,were,given,twice,weekly,weeks,popu,lation,Main,outcome,measures,Outcome,including,Oswestry,Disability,Index,Quadruple,Visual,Analogue,Scale,blood,serum,levels,reactive,protein,tumour,necrosis,interleukin,dimensions,Short,Form,Health,Survey,scale,assessed,baseline,months,following,period,Results,Compared,produced,significance,declines,virtually,physiological,disability,accompanied,gains,quality,life,percentages,whose,biomarkers,lay,side,normative,range,achieved,but,not,Conclusion,indicated,compared,clinically,statistically,significant,reductions,improvements,registration,was,registered,Australian,New,Zealand,Clinical,Trials,Registry,No
AB值:
0.55559
相似文献
A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
Zheng Xiang;Zhang Weijie;Zhou Hua;Cao Ronghua;Shou Zhangfei;Zhang Shuwei;Cheng Ying;Chen Xuchun;Ding Chenguang;Tang Zuofu;Li Ning;Shi Shaohua;Zhou Qiang;Chen Qiuyuan;Chen Gang;Chen Zheng;Zhou Peijun;Hu Xiaopeng;Zhang Xiaodong;Na Ning;Wang Wei-Department of Urology, Capital Medical University Beijing Chaoyang Hospital, Beijing 100020, China;Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430032, China;Kidney Transplantation Dialysis Center, The Second People’s Hospital of Shanxi Province, Taiyuan, Shanxi 030012, China;Department of Organ Transplantation, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong 510120, China;Department of Nephrology, Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang 310000, China;Department of Urology, Ningbo Yinzhou Number. 2 Hospital, Ningbo, Zhejiang 315000, China;Department of Organ Transplantation, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China;Institute of Kidney Transplantation, The First Affiliated Hospital, Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China;Department of Kidney, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China;Department of Kidney, Southwest Hospital, The First Hospital Affiliated to The Third Military Medical University (Army Medical University), Chongqing 400000, China;Organ Transplant Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, China;Kidney Transplantation Center, Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200000, China
Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study
Zhu Huiyun;Pan Xue;Zhang Li;Sun Hongxin;Fan Huizhen;Pan Zhongwei;Huang Caibin;Shi Zhenwang;Ding Jin;Wang Qi;Du Yiqi;Lyu Nonghua;Li Zhaoshen-Department of Gastroenterology, Changhai Hospital of Navy Military Medical University, Shanghai 200433, China;Drug Clinical Trial Institution, Changhai Hospital of Navy Military Medical University, Shanghai 200433, China;Department of Gastroenterology, Yichun People’s Hospital, Yichun, Jiangxi 336028, China;Department of Gastroenterology, Meihekou Central Hospital, Meihekou, Jilin 135099, China;Department of Gastroenterology, The First Affiliated Hospital of Gannan Medical College, Ganzhou, Jiangxi 341001, China;Department of Gastroenterology, Hefei Second People’s Hospital, Hefei, Anhui 230011, China;Department of Gastroenterology, Jinhua Central Hospital, Jinhua, Zhejiang 321099, China;Department of Gastroenterology, Anqing Municipal Hospital, Anqing, Anhui 246004, China;Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
An international multicentric phase Ⅲ randomized controlled trial of time-acupoints-space acupuncture for the prevention of chemotherapy-induced fatigue in patients with early stage breast cancer:a study protocol
Saghachian Mahasti;Barry Caroline;Asselain Bernard;LI Yunfen;NIE Jianyun;LIU Dequan;CHEN Dedian;CHEN Chunxin;Laura Estevez;LI Wenhui;Jean-Pierre Armand;ZHU Miansheng;JU Liya-Institute Gustave Roussy,Paris,France;Research Center of Epidemiology and public health,Paris,France;Institute Curie of Paris,Paris,France;Yunnan Cancer Hospital,Third Affiliated Hospital of Kunming Medical University,Kunming,China;PreciMed Platform Europe,Paris,France,,MD Anderson Cancer Hospital,Madrid,Spain;ARIATAS Association pour la Recherche et l'Information de l'Acupuncture Time-Acupoints-Space,Paris,France
Efficacy and safety of a sequential treatment with clearing heat and eliminating phlegm and tonifying Qi and activating blood circulation in treating acute ischemic stroke:study protocol for a randomized controlled trial
ZHOU Ziyi;WAN Can;ZHAO Yuanqi;LIU Xiangzhe;GAO Ying;AN Hongwei;LI Lejun;ZHANG Huili;YU Xiaofei;ZHANG Xinchun;WANG Huijuan;SHI Qing;WEI Chunhua;CHEN Jie;HUANG Wenguo;CHEN Junbin;HU Mingzhe;CAI Yefeng-Department of Neurology,Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120,China;The Second Clinical College of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;the Second Clinical College of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Neurology,The First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou 450000,China;Department of Neurology,Shenyang Second Hospital of Traditional Chinese Medicine,Shenyang 110100,China;Department of Neurology and Stroke Center,Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine,Beijing 100700,China;Department of Neurology,Liuzhou Traditional Chinese Medical Hospital,Liuzhou 545001,China;Department of Neurology,Wuxi Traditional Chinese Medicine Hospital,Wuxi 214071,China;Department of Neurology,Qinhuangdao City Hospital of Traditional Chinese Medicine,Qinhuangdao 066000,China;Department of Neurology,Shanghai Shuguang Hospital,Shanghai 200120,China;Department of Neurology,the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China;Department of Neurology,Jiangmen Wuyi Hospital of Traditional Chinese Medicine,Jiangmen 529000,China;Department of Neurology,Nanshi Hospital Affiliated to Henan University,Nanyang 473065,China;Department of Neurology,Shanxi Province Hospital of Traditional Chinese Medicine,Xi'an 710003,China;Department of Neurology,Maoming Hospital of Traditional Chinese Medicine,Maoming 525000,China;Department of Neurology,the Northern Guangdong People's Hospital,Shaoguan 512025,China;Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, China
Wenshen Jianpi recipe(温肾健脾方)induced immune reconstruction and redistribution of natural killer cell subsets in immunological non-responders of human immunodeficiency virus/acquired immune deficiency syndrome:a randomized controlled trial
TAO Zhuang;WANG Jian;CHEN Xin;LI Yonghong;YAN Yuguang;ZHANG Ao;ZOU Wen;LIU Ying-Research Center of AIDS Treatment with Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Department of Integrated Traditional Chinese and Wetern Medicine,Kunming Hospital of Traditional Chinese Medicine,Kunming 650000,China;Department of Infection,No.6 People's Hospital of Shenyang City,Shenyang 110006,China;University of Chinese Academy of SoCIal SCIences,Beijing,100102,China
Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patients with pneumoconiosis:a pilot double-blind,randomized,and placebo-controlled study
Jiansheng Li;Hulei Zhao;Yang Xie;Jieya Li;Qingwei Li;Xuexin Chen;Weiyu Zhang-Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province&Education Ministry of China,Henan University of Chinese Medicine,Zhengzhou 450046,China;Henan Key Laboratory of Chinese Medicine for Respiratory Disease,Henan University of Chinese Medicine,Zhengzhou 450046,China;Department of Respiratory Diseases,The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450000,China;Department of Pneumoconiosis,Henan Hospital for Occupational Diseases,Zhengzhou 450052,China;Department of Respiratory Diseases,Jiaozuo Coal Industry Group Co.,Ltd.Central Hospital,Jiaozuo 454000,China;Department of Pneumoconiosis,Yima Coal Industry Group Co.,Ltd.General Hospital,Yima 472300,China
Lingguizhugan Decoction,a Chinese herbal formula,improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease:a translational approach
Liang Dai;Jingjuan Xu;Baocheng Liu;Yanqi Dang;Ruirui Wang;Lijie Zhuang;Dong Li;Lulu Jiao;Jianying Wang;Lei Zhang;Linda L.D.Zhong;Wenjun Zhou;Guang Ji-Institute of Digestive Diseases,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Clinical Research Academy,Peking University Shenzhen Hospital,Shenzhen 518032,China;Department of Integrated Traditional and Western Medicine,Jinling Hospital,Medical School of Nanjing University,Nanjing 210002,China;Shanghai Innovation Centre of TCM Health Service,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Sanlin Health Centre of Pudong New District,Shanghai 200120,China;Zhangjiang Health Centre of Pudong New District,Shanghai 201203,China;Beicai Health Centre of Pudong New District,Shanghai 201204,China;Hong Kong Chinese Medicine Study Centre,Hong Kong Baptist University,Hong Kong 999077,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。